MeSH D000013 - congenital abnormalities
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009358:Hereditary congenital and neonatal diseases and abnormalities
0 Companies
0 Drugs
Success rate
D000014:Drug-induced abnormalities
D000015:Multiple abnormalities
0 Companies
0 Drugs
Success rate
D000016:Radiation-induced abnormalities
0 Companies
0 Drugs
Success rate
D004065:Digestive system abnormalities
0 Companies
0 Drugs
Success rate
D005124:Eye abnormalities
0 Companies
0 Drugs
Success rate
D009008:Severe teratoid abnormalities
0 Companies
0 Drugs
Success rate
D009139:Musculoskeletal abnormalities
0 Companies
0 Drugs
Success rate
D009421:Nervous system malformations
0 Companies
0 Drugs
Success rate
D012857:Situs inversus
0 Companies
0 Drugs
Success rate
D012868:Skin abnormalities
0 Companies
0 Drugs
Success rate
D014564:Urogenital abnormalities
0 Companies
0 Drugs
Success rate
D015619:Respiratory system abnormalities
0 Companies
0 Drugs
Success rate
D018376:Cardiovascular abnormalities
0 Companies
0 Drugs
Success rate
D018640:Stomatognathic system abnormalities
0 Companies
0 Drugs
Success rate
D025063:Chromosome disorders
0 Companies
0 Drugs
Success rate
D044148:Lymphatic abnormalities
0 Companies
0 Drugs
Success rate
D050033:Thyroid dysgenesis
0 Companies
0 Drugs
Success rate
D058540:Aicardi syndrome
0 Companies
0 Drugs
Success rate
D065630:Diaphragmatic hernias congenital
0 Companies
0 Drugs
Success rate
D065817:Congenital microtia
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%0/3
Phase 2
50%1/2
Phase 3
50%1/2
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use